World’s largest clinical trial on aspirin to stop cancer returning launches today

THE world’s largest ever clinical trial looking at whether taking aspirin every day stops some of the most common cancers coming back, launches today. The Add-Aspirin phase III trial, the largest of its kind and funded by the NIHR HTA Programme and Cancer Research UK, aims to find out if taking aspirin every day for...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news